Healthpeak Properties (NYSE:DOC) Releases FY24 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY24 earnings guidance on Monday. The company provided earnings per share guidance of $1.80-$1.82 for the period, compared to the consensus earnings per share estimate of $1.80.

Healthpeak Properties Trading Up 0.0 %

DOC stock traded up $0.01 during mid-day trading on Monday, reaching $20.87. 5,004,884 shares of the stock traded hands, compared to its average volume of 5,741,760. Healthpeak Properties has a 52-week low of $16.01 and a 52-week high of $23.26. The company has a market cap of $14.60 billion, a P/E ratio of 44.38, a P/E/G ratio of 2.32 and a beta of 1.13. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The stock’s fifty day moving average is $22.26 and its 200-day moving average is $21.08.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. During the same quarter last year, the company earned $0.45 EPS. The business’s revenue for the quarter was up 25.9% compared to the same quarter last year. As a group, sell-side analysts expect that Healthpeak Properties will post 1.8 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a $0.30 dividend. The ex-dividend date was Monday, November 4th. This represents a $1.20 annualized dividend and a yield of 5.75%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 255.32%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Scotiabank lifted their price target on shares of Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a report on Monday, September 9th. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and upped their target price for the stock from $20.00 to $28.00 in a research note on Monday, October 21st. Royal Bank of Canada increased their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Finally, Robert W. Baird raised their price target on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $22.86.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.